Literature DB >> 15850637

Malaria control in Afghanistan: progress and challenges.

Jan Kolaczinski1, Kate Graham, Abdullah Fahim, Simon Brooker, Mark Rowland.   

Abstract

From the 1950s until 1979 malaria control in Afghanistan was implemented through a vertical programme managed by the government, but little of the original programme remained functional by the early 1990s. Delivery of basic health care including malaria diagnosis and treatment was done by non-governmental organisations (NGOs) and UN agencies, which organised cross-border operations from Pakistan and Iran and placed much less emphasis on vertical programming. From 1992 the situation in the east of Afghanistan became stable enough to allow the establishment of a network of NGO-supported clinics and to introduce standardised training and monitoring of microscopists and clinical staff, coordinated by a lead agency specialising in malaria. After the collapse of the Taliban in 2001 and the subsequent establishment of an interim government, the first steps in health-system rehabilitation have been taken. The gradual integration of malaria control into routine health-care delivery is planned. This process should be guided by the knowledge and experience gained during the complex emergency and a focus on malaria should be maintained until the disease is brought under control.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15850637     DOI: 10.1016/S0140-6736(05)66423-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  27 in total

Review 1.  Defining the global spatial limits of malaria transmission in 2005.

Authors:  C A Guerra; R W Snow; S I Hay
Journal:  Adv Parasitol       Date:  2006       Impact factor: 3.870

Review 2.  Malaria vector control: from past to future.

Authors:  Kamaraju Raghavendra; Tapan K Barik; B P Niranjan Reddy; Poonam Sharma; Aditya P Dash
Journal:  Parasitol Res       Date:  2011-01-13       Impact factor: 2.289

3.  Compliance with antimalaria chemoprophylaxis in a combat zone.

Authors:  Michael Brisson; Paul Brisson
Journal:  Am J Trop Med Hyg       Date:  2012-04       Impact factor: 2.345

4.  Dihydroartemisinin-piperaquine versus chloroquine to treat vivax malaria in Afghanistan: an open randomized, non-inferiority, trial.

Authors:  Ghulam Rahim Awab; Sasithon Pukrittayakamee; Mallika Imwong; Arjen M Dondorp; Charles J Woodrow; Sue Jean Lee; Nicholas P J Day; Pratap Singhasivanon; Nicholas J White; Faizullah Kaker
Journal:  Malar J       Date:  2010-04-21       Impact factor: 2.979

5.  Towards malaria risk prediction in Afghanistan using remote sensing.

Authors:  Farida Adimi; Radina P Soebiyanto; Najibullah Safi; Richard Kiang
Journal:  Malar J       Date:  2010-05-13       Impact factor: 2.979

6.  Malaria elimination trend from a hypo-endemic unstable active focus in southern Iran: predisposing climatic factors.

Authors:  M D Moemenbellah-Fard; V Saleh; O Banafshi; T Dabaghmanesh
Journal:  Pathog Glob Health       Date:  2012-10       Impact factor: 2.894

Review 7.  Malaria resurgence: a systematic review and assessment of its causes.

Authors:  Justin M Cohen; David L Smith; Chris Cotter; Abigail Ward; Gavin Yamey; Oliver J Sabot; Bruno Moonen
Journal:  Malar J       Date:  2012-04-24       Impact factor: 2.979

8.  Malaria control under the Taliban regime: insecticide-treated net purchasing, coverage, and usage among men and women in eastern Afghanistan.

Authors:  Natasha Howard; Ahmad Shafi; Caroline Jones; Mark Rowland
Journal:  Malar J       Date:  2010-01-06       Impact factor: 2.979

9.  Malaria reemergence in northern Afghanistan.

Authors:  Michael K Faulde; Ralf Hoffmann; Khair M Fazilat; Achim Hoerauf
Journal:  Emerg Infect Dis       Date:  2007-09       Impact factor: 6.883

10.  Malaria control in Timor-Leste during a period of political instability: what lessons can be learned?

Authors:  Joao S Martins; Anthony B Zwi; Nelson Martins; Paul M Kelly
Journal:  Confl Health       Date:  2009-12-16       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.